3 completed. 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow TZD: new trials by email Literature Review of TZD trials Research Report on TZD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes lixisenatide AVE0010, biguanide, TZD - Type 2 Diabetes Mellitus | Phase 3 | Completed | Sanofi | 294 | 2013-09-01 | 2015-08-04 |
| "TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM Pioglitazone - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Pennington Biomedical Research Center | 24 | 2006-11-01 | 2015-12-18 |
| Evaluating the Effects of Electroacupuncture and Rosiglitazone Combined Therapy EA + Rosiglitazone, TZD - Type 2 Diabetes Mellitus With Features of Insulin Resistance | Phase 2 | Completed | China Medical University Hospital | 49 | 2006-04-01 | 2012-04-13 |
Diabetes Mellitus, Type 2 (2) · Insulin Resistance (1)
China Medical University Hospital (1) · Pennington Biomedical Research Center (1) · Sanofi (1)
Japan (1) · Taiwan (1) · United States (1)
Shih-Liang Chang, PhD (1) · Steven R Smith, M.D. (1)